Get startedLog in
    Picture of Onkure Therapeutics logo

    OKUR — Onkure Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Reneo Pharmaceuticals Achieves Target Enrollment

    Picture of Onkure Therapeutics logoOnkure Therapeutics
    14/03/2023 11:33
    March 14 (Reuters) - Reneo Pharmaceuticals Inc  RPHM.O :
    * RENEO PHARMACEUTICALS ACHIEVES TARGET ENROLLMENT IN THE
PIVOTAL
STRIDE STUDY OF MAVODELPAR (REN001) IN PRIMARY MITOCHONDRIAL
MYOPATHIES
    * RENEO PHARMACEUTICALS INC - TOPLINE DATA FROM STRIDE STUDY
ARE
EXPECTED IN Q4 OF 2023

Source text for Eikon:  ID:nGNX87q1Wv 
Further company coverage:  RPHM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Onkure Therapeutics

    See all news